fk-866 and Skin-Neoplasms

fk-866 has been researched along with Skin-Neoplasms* in 2 studies

Trials

1 trial(s) available for fk-866 and Skin-Neoplasms

Article	Year
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial. JAMA dermatology, 2016, 07-01, Volume: 152, Issue:7 Topics: Acrylamides; Adult; Aged; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Safety; Piperidines; Prognosis; Risk Assessment; Skin Neoplasms; Survival Analysis; Treatment Outcome	2016

Article

Year

Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.

JAMA dermatology, 2016, 07-01, Volume: 152, Issue:7

Topics: Acrylamides; Adult; Aged; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Safety; Piperidines; Prognosis; Risk Assessment; Skin Neoplasms; Survival Analysis; Treatment Outcome

2016

Other Studies

1 other study(ies) available for fk-866 and Skin-Neoplasms

Article	Year
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. Pigment cell & melanoma research, 2013, Volume: 26, Issue:1 Topics: Acrylamides; Cell Death; Cell Line, Tumor; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Nicotinamide Phosphoribosyltransferase; Piperidines; Skin Neoplasms	2013